ANI Pharmaceuticals Inc

2026. g. 24. aug. 20:13 UTC

ANI Pharmaceuticals Inc. shares are higher in after-market trading, recovering from four consecutive sessions of losses amid ongoing geopolitical concerns.

2026. g. 21. aug. 20:01 UTC

ANI Pharmaceuticals Inc. shares are lower today, continuing a decline since Thursday's close and trading near the lower end of its one-month range.

2026. g. 20. aug. 19:46 UTC

ANI Pharmaceuticals is trading lower today, having peaked earlier in the session. The stock remains below its 20-day moving average amid strong labor market data.

2026. g. 19. aug. 23:41 UTC

ANI Pharmaceuticals Inc. shares declined after-market, falling sharply below the 20-day moving average and near the lower end of their one-month trading range.

2026. g. 18. aug. 20:12 UTC

ANI Pharmaceuticals shares are higher in after-market trading, despite no specific news. The asset remains near the lower end of its one-month range.

2026. g. 17. aug. 19:36 UTC

ANI Pharmaceuticals reports $266 million in Q2 revenue, exceeding estimates. However, shares are lower amid guidance concerns and broader market declines.

2026. g. 14. aug. 19:26 UTC

ANI Pharmaceuticals is trading higher, recovering from an early drop amid broader market concerns following a decline in U.S. retail sales for July.

2026. g. 13. aug. 22:16 UTC

ANI Pharmaceuticals Inc. shares showed routine trading activity in after-market hours, remaining roughly flat since Thursday's close and near the lower end of its one-month range.

2026. g. 12. aug. 19:36 UTC

ANI Pharmaceuticals Inc shares are higher during Wednesday's session amid a broader market optimism following a modest increase in inflation data.

2026. g. 11. aug. 19:56 UTC

ANI Pharmaceuticals shares are lower despite a 25.9% sales increase to $266 million. Full-year revenue guidance of $1.11 billion fell short of estimates.

2026. g. 10. aug. 20:01 UTC

ANI Pharmaceuticals shares are lower today as analysts cut price targets, despite strong Q2 earnings that exceeded estimates and revenue growth.

2026. g. 7. aug. 20:03 UTC

ANI Pharmaceuticals shares are lower after reporting Q2 revenue of $266 million and providing full-year guidance of $1.11 billion, below analyst estimates.

2026. g. 6. aug. 19:51 UTC

ANI Pharmaceuticals shares are rising amid high trading volume ahead of its Q2 earnings report. Analysts expect revenue growth to decelerate compared to last year.

2026. g. 5. aug. 20:06 UTC

ANI Pharmaceuticals Inc shares are higher today, though no specific news explains the move. Market sentiment has improved amid a decline in crude oil prices.

2026. g. 4. aug. 19:33 UTC

ANI Pharmaceuticals is declining today despite noted revenue growth and improved cash flow margins, as sector regulation raises caution about earnings potential.

2026. g. 3. aug. 19:46 UTC

ANI Pharmaceuticals is trading higher since Friday's close, despite a flat overall session. The stock remains near the lower end of its one-month range.

2026. g. 31. jūl. 20:06 UTC

ANI Pharmaceuticals Inc. shares are declining amid unusual volatility, with trading lower since Thursday as inflation concerns rise alongside US Treasury yields and crude oil prices.

2026. g. 30. jūl. 20:09 UTC

ANI Pharmaceuticals Inc. shares are lower during Thursday's session, following a notable dip in late morning trading amid mixed economic signals impacting broader market conditions.

2026. g. 29. jūl. 19:19 UTC

ANI Pharmaceuticals shares are higher, rebounding after an earlier pullback. Market sentiment is influenced by expectations for the Federal Reserve's monetary policy announcement today.

2026. g. 28. jūl. 20:02 UTC

ANI Pharmaceuticals is advancing today, continuing an upward trend since Monday, despite declines in broader market sectors, particularly technology stocks in Asia.

2026. g. 24. jūl. 20:06 UTC

ANI Pharmaceuticals shares are lower today amid mixed market sentiment for healthcare stocks. The company plans to discuss its Q2 2026 financial results on August 7, 2026.

2026. g. 22. jūl. 20:01 UTC

Shares of ANI Pharmaceuticals are lower amid concerns over potential tariffs on imported generic drugs. The stock is near the lower end of its one-month range.

2026. g. 21. jūl. 20:12 UTC

ANI Pharmaceuticals Inc. shares are lower in after-market trading, positioned below the 20-day moving average and near the lower end of their one-month range.

2026. g. 20. jūl. 19:46 UTC

ANI Pharmaceuticals shares are lower despite positive results from the Phase 4 SYNCHRONICITY trial, which may support expanded use of ILUVIEN.